Academic literature on the topic 'Eisenmenger syndrome'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Eisenmenger syndrome.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Eisenmenger syndrome"
Campos, Fernando Peixoto Ferraz de, and Luiz Alberto Benvenuti. "Eisenmenger Syndrome." Autopsy and Case Reports 7, no. 1 (2017): 5–7. http://dx.doi.org/10.4322/acr.2017.006.
Full textArvanitaki, Alexandra, Michael A. Gatzoulis, Alexander R. Opotowsky, Paul Khairy, Konstantinos Dimopoulos, Gerhard-Paul Diller, George Giannakoulas, et al. "Eisenmenger Syndrome." Journal of the American College of Cardiology 79, no. 12 (March 2022): 1183–98. http://dx.doi.org/10.1016/j.jacc.2022.01.022.
Full textPrevite, Joseph, and Panchapakesan Haran. "Eisenmenger Syndrome." Seminars in Cardiothoracic and Vascular Anesthesia 5, no. 1 (March 2001): 67–78. http://dx.doi.org/10.1053/scva.2001.21556.
Full textBeghetti, Maurice, and Nazzareno Galiè. "Eisenmenger Syndrome." Journal of the American College of Cardiology 53, no. 9 (March 2009): 733–40. http://dx.doi.org/10.1016/j.jacc.2008.11.025.
Full textDuke, Martin. "Victor Eisenmenger (1864–1932): The man behind the syndrome." Journal of Medical Biography 25, no. 1 (July 9, 2016): 52–55. http://dx.doi.org/10.1177/0967772014555301.
Full textThiene, Gaetano. "Eisenmenger Syndrome Revisited." World Journal for Pediatric and Congenital Heart Surgery 8, no. 6 (November 2017): 726–34. http://dx.doi.org/10.1177/2150135117727259.
Full textMarwali, Eva M., Novik Budiwardhana, and Anna U. Rahayoe. "Inhaled prostacyclin for Eisenmenger syndrome complicated with miliary tuberculosis." Paediatrica Indonesiana 51, no. 4 (August 30, 2011): 241. http://dx.doi.org/10.14238/pi51.4.2011.241-4.
Full textNashat, Heba, Aleksander Kempny, Colm McCabe, Laura C. Price, Carl Harries, Rafael Alonso-Gonzalez, Michael A. Gatzoulis, Stephen J. Wort, and Konstantinos Dimopoulos. "Eisenmenger syndrome: current perspectives." Research Reports in Clinical Cardiology Volume 8 (February 2017): 1–12. http://dx.doi.org/10.2147/rrcc.s117838.
Full textJeyamalar, R., V. Sivanesaratnam, and P. Kuppuvelumani. "Eisenmenger Syndrome in Pregnancy." Australian and New Zealand Journal of Obstetrics and Gynaecology 32, no. 3 (February 13, 2008): 275–77. http://dx.doi.org/10.1111/j.1479-828x.1992.tb01965.x.
Full textRosenzweig, Erika B., Darryl Abrams, Mauer Biscotti, Diane Kerstein, Daphnie Drassinower, Daniel Brodie, and Matthew Bacchetta. "Eisenmenger Syndrome and Pregnancy." ASAIO Journal 64, no. 1 (2018): e8-e10. http://dx.doi.org/10.1097/mat.0000000000000548.
Full textDissertations / Theses on the topic "Eisenmenger syndrome"
Bowater, Sarah Elizabeth. "Physiological adaptations to chronic hypoxemia in Eisenmenger syndrome." Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/4567/.
Full textArnott, Clare. "Studies of the right ventricle and pulmonary vasculature in humans - imaging and outcomes." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/17780.
Full textBrabet, Monique. "Conduite à tenir anesthésique pour l'accouchement d'une patiente souffrant d'un syndrome de Eisenmenger : à propos d'un cas." Montpellier 1, 1989. http://www.theses.fr/1989MON11262.
Full textClavé, Mariana Meira. "Tratamento específico em hipertensão arterial pulmonar avançada associada a cardiopatias congênitas: aspectos clínicos, bioquímicos e prognósticos." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-02072018-153122/.
Full textINTRODUCTION: Pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH) is a particular form of pulmonary vascular disease with a number of complications. Patients with advanced CHD-PAH are deemed inoperable, and may present with chronic hypoxemia and secondary erythrocytosis due to right-to-left shunting across the cardiac communications. The present study was aimed at analyzing the response to 2 phosphodiesterase type 5 inhibitors (PDE5is), namely sildenafil and tadalafil, which were administered for 6 months. The drugs had been previously approved for management of PAH in general. However, there has been scarce literature on their use in the specific setting of CHD-PAH. We wished to investigate potential effects beyond their actions as vasodilators. METHODS: Thirty-one patients with advanced CHD-PAH were enrolled (age 10 to 54 years). Most of them had systemic oxygen desaturation with elevated hematocrit. Sildenafil and tadalafil were administered orally (respectively, 20 mg t.i.d and single daily dose of 40 mg). The physical capacity was assessed by registering the 6-minute walked distance (6-minute walk test, American Thoracic Society protocol). Health-related quality of life was assessed using the SF-36 generic questionnaire. Circulating levels of microvascular dysfunction markers were analyzed by enzyme-linked immunoassays. All measurements were performed at baseline, 3 months and 6 months of PDE5i administration. Using a larger patient population with retrospective as well as prospective data analysis, we looked for potential predictors of prognosis. RESULTS: Both therapies were associated with improvement of the physical capacity (functional class and 6-minute walked distance, p < 0.05), hematocrit and hemoglobin level (p < 0.05), and health-related quality of life (physical and mental components, p < 0.05). Compared to controls, patients had elevated baseline plasma levels of beta-thromboglobulin (beta-TG, p=0.002), P-selectin (p=0.018), tissue-type plasminogen activator (t-PA, p=0.005) and von Willebrand factor antigen (VWF:Ag, p=0.005), while thrombomodulin was importantly reduced (TM, p < 0.001). Tadalafil administration was followed by improvement of beta-TG (p=0.004), t-PA (p=0.003) and TM level (p=0.046), while P-selectin was improved by sildenafil only (p=0.034). VWF:Ag improved significantly, but only transiently in the sildenafil group (p=0.019). Using an extended population which included additional patients from previous studies of ours (the extended cohort consisted of 75 individuals), we analyzed data collected at the beginning of follow-up for all subjects, and treatment-related data as well. A number of clinical and laboratory parameters were tested for their possible correlation with event-free survival (9-year survival analysis). In this part of the study, patients were on monotherapy or combination therapy with PDE5is (sildenafil or tadalafil) and endothelin receptor antagonists (bosentan or ambrisentan). Univariate, bivariate and multivariate analyses were used to identify four predictors of a more worrisome prognosis: 1, a shorter time of exposure to specific PAH therapies (p < 0.001); 2, an advanced functional class at entry (p=0.010); 3, a depressed right ventricular systolic function (p=0.010); and 4, high circulating levels of VWF:Ag (p=0.013). A shorter exposure to PAH therapies was characterized as an independent predictor of poor outcome. CONCLUSIONS AND COMMENTS: Our observations point towards beneficial effects of PDE5is in advanced CHD-PAH. Importantly, the observed effects were not only on the physical capacity, and quality of life, but also biological markers of microvascular injury potentially related to disease progression and/or complications. Furthermore, long-term patient observation showed that a longer exposure to PAH drugs (including PDE5is) was beneficial, thus emphasizing the need for early initiation of therapies. Because only oral drugs were used, results may be relevant for countries and regions with limited access to PAH-specific medications
Hascoët, Sébastien. "Thérapies avancée de l'hypertension artérielle pulmonaire associée aux cardiopathies congénitales Pumpless Lung Assist as a Bridge to Medical Therapy in a Teenager With Pulmonary Arterial Hypertension and Partial Anomalous Pulmonary Venous Return Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impact of Current Therapeutic Approach Including a High-Priority Allocation Programme on Outcomes Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study Long-term outcomesofpulmonaryarterial hypertension underspecific drugtherapyin Eisenmenger syndrome." Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASQ010.
Full textAbstract: Congenital heart disease is the most common birth defect. Thanks to advances in surgical management, about 90% of children with congenital heart disease now live to adulthood. Nevertheless, the clinical course of these patients may be marked by complications, including pulmonary arterial hypertension. It may develop secondary to the absence or delay of treatment in childhood or to residual lesions. It is associated with an altered prognosis, primarily due to ventricular failure. Pulmonary arterial hypertension in these patients is characterized by variability in hemodynamic aspects depending on the underlying anatomical lesions. Its management remains variable, complex and controversial. Correction of underlying predisposing congenital heart disease is recommended or contraindicated depending on the degree of severity of pulmonary arterial hypertension. Specific pulmonary vasodilator drug therapies may be beneficial in more advanced disease. Patients with end stage disease may benefit from cardiopulmonary transplantation. The main objective of this thesis was to study the hemodynamic and prognostic impact of the different advanced therapeutic approaches currently available for the management of pulmonary arterial hypertension associated with congenital heart disease. Specific drug therapies, percutaneous shunt correction, circulatory support and cardiopulmonary transplant were studied. This thesis has shown that proactive management of pulmonary arterial hypertension in patients with congenital heart disease is associated with improved hemodynamic parameters, clinical parameters and improved prognosis. The results of this thesis call for further use and evaluation of advanced therapies to refine clinical management algorithms
Luchner, Lisa [Verfasser]. "Langzeittherapie mit Bosentan bei Patienten mit Eisenmenger-Syndrom / Lisa Luchner." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1218077042/34.
Full textScherber, Philipp Robert [Verfasser], and Hashim [Akademischer Betreuer] Abdul-Khaliq. "Analyse der myokardialen Funktion mit der neuen 2D-Strain Echokardiografie bei Patienten mit Eisenmenger-Syndrom vor und nach der Behandlung mit Bosentan / Philipp Robert Scherber. Betreuer: Hashim Abdul-Khaliq." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2011. http://d-nb.info/1051095875/34.
Full textScherber, Philipp Robert Verfasser], and Hashim [Akademischer Betreuer] [Abdul-Khaliq. "Analyse der myokardialen Funktion mit der neuen 2D-Strain Echokardiografie bei Patienten mit Eisenmenger-Syndrom vor und nach der Behandlung mit Bosentan / Philipp Robert Scherber. Betreuer: Hashim Abdul-Khaliq." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2011. http://nbn-resolving.de/urn:nbn:de:bsz:291-scidok-40361.
Full textBooks on the topic "Eisenmenger syndrome"
Thorne, Sara, and Sarah Bowater. Eisenmenger syndrome. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759959.003.0010.
Full textKatritsis, Demosthenes G., Bernard J. Gersh, and A. John Camm. Eisenmenger syndrome. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199685288.003.0241.
Full textThorne, Sara, and Paul Clift, eds. The Eisenmenger syndrome. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199228188.003.0016.
Full textSerfass, Evan R., and Justin D. Ramos. Ventricular Septal Defect. Edited by Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi, and Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0007.
Full textDob, Daryl P., Elspeth E. Pickering, and Michael A. Gatzoulis. Moderate to complex congenital heart disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198713333.003.0040.
Full textBook chapters on the topic "Eisenmenger syndrome"
Gupta, Ruchi, Shirah Shore, Maria M. Rodriguez, and Marco Ricci. "Eisenmenger Syndrome." In Principles of Pulmonary Protection in Heart Surgery, 171–77. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84996-308-4_19.
Full textMichelow, Marilyn Diane. "Eisenmenger Syndrome." In Anesthesiology, 41–46. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-50141-3_7.
Full textInai, Kei, Alexander K. C. Leung, Jouni Uitto, Gerhard-Paul Diller, Michael A. Gatzoulis, John-John B. Schnog, Victor E. A. Gerdes, et al. "Eisenmenger Syndrome." In Encyclopedia of Molecular Mechanisms of Disease, 567–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_539.
Full textYung, Delphine. "Pulmonary Hypertension/Eisenmenger Syndrome." In Textbook of Clinical Pediatrics, 2413–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_257.
Full textD’Alto, Michele, and Giovanni Maria Di Marco. "Eisenmenger Syndrome in Patients with Down Syndrome." In Pulmonary Hypertension in Adult Congenital Heart Disease, 279–89. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46028-4_18.
Full textOwusu-Ansah, Kevin, Zeksen Lim, and Gruschen R. Veldtman. "Pulmonary Arterial Hypertension in Eisenmenger Syndrome." In Adult Congenital Heart Disease, 57–75. Oxford, UK: Blackwell Publishing Ltd., 2009. http://dx.doi.org/10.1002/9781444311846.ch5.
Full textBroberg, Craig S. "Eisenmenger Syndrome: Pathophysiology and Haematologic Effects." In Pulmonary Hypertension in Adult Congenital Heart Disease, 29–44. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46028-4_3.
Full textMahli, Ahmet, and Demet Coskun. "Anesthesia for Pregnant Patients with Eisenmenger Syndrome." In Obstetric Anesthesia for Co-morbid Conditions, 219–25. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-93163-0_15.
Full textEdwards, Christopher. "Pregnancy Plus Atrial Septal Defect vs Eisenmenger Syndrome." In Clinical Anesthesiology, 325–28. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8696-1_39.
Full textSadeghpour, Anita, and Azin Alizadehasl. "Pulmonary Hypertension Associated with Congenital Heart Disease, Eisenmenger Syndrome." In Comprehensive Approach to Adult Congenital Heart Disease, 117–24. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6383-1_15.
Full textConference papers on the topic "Eisenmenger syndrome"
Anderson, D. K., and C. E. Bennett. "Recurrent Hemoptysis in the Setting of Eisenmenger Syndrome." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6754.
Full textTacer, Ana, Nejc Pavsic, Polona Koritnik, Katja Prokselj, TT Schlegel, and Vito Starc. "High-Resolution Electrocardiography in Patients with Eisenmenger Syndrome." In 2021 Computing in Cardiology (CinC). IEEE, 2021. http://dx.doi.org/10.23919/cinc53138.2021.9662871.
Full textRowan, CA, D. Lederer, KS Lee, and EB Rosenzweig. "Ambrisentan: Safety and Efficacy in the Treatment of Eisenmenger Syndrome." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4919.
Full textDai, Z. K., I. C. Chen, J. H. Hsu, Y. H. Wu, and Y. C. Liu. "The Long Term Experience on Treatment for Adult Patients with Eisenmenger Syndrome." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5075.
Full textPapalexiou, P., G. Karpetas, M. Spyraki, E. Dimitriou, S. Antoniou, A. Zotou, and A. Siampalioti. "B252 Combination of peripheral nerve blocks in a patient with eisenmenger syndrome." In ESRA Abstracts, 39th Annual ESRA Congress, 22–25 June 2022. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/rapm-2022-esra.326.
Full textBarst, Robyn J., D. Dunbar Ivy, Erika Rosenzweig, Aimee J. Foreman, Michelle Turner, Leslie A. Meltzer, and Michael McGoon. "Characteristics And Four-Year Outcomes Of Patients With Eisenmenger Syndrome In REVEAL." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4793.
Full textZebadua, R., J. C. López, N. G. Zayas, J. Sandoval, M. Villalobos-Pedroza, A. Cruz, D. K. Hernández, J. F. Canul, T. Pulido, and N. G. Zayas Hdz. "Long-term clinical assessment in patients with Eisenmenger Syndrome treated with macitentan." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.4261.
Full textYang-Ting, S., J. Aboulhosn, JS Child, XG Sun, and KE Sietsema. "Effect of Pulmonary Vasodilator Therapy on Ventilatory Efficiency in Adults with Eisenmenger Syndrome." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2044.
Full textChao, A., P. Chan, D. Shavelle, S. Ganesh, and B. Yaghmour. "Embolic Acute Myocardial Infarction in Young Adult with Congenital Heart Disease and Eisenmenger Syndrome." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1925.
Full textSathianandan, Sobitha, Bhavin Rawal, Heba Nashat, Laura Price, Simon Padley, Kostas Dimopoulos, Tom Semple, and John Wort. "A retrospective review of computed tomography (CT) findings in Eisenmenger Syndrome and their prognostic implications." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4757.
Full text